CDKN2A and neoplasm: Cytoplasmic reactivity is often regarded as unexpected, unspecific event.[36] Some consider only nucleic p16INK4a labeling in tumor cells to be positive and ignore cytoplasmic staining.[16,32] Others state that both nucleic and cytoplasmic immunoreactivities in tumor cells are characteristic and are indeed due to p16INK4a expression.